BETA
This is a BETA experience. You may opt-out by clicking here

More From Forbes

Edit Story

MSA Safety Shares Slide 11.6% Below Bruggeworth's Purchase Price

Following
This article is more than 9 years old.

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 10, MSA Safety Inc's Director, Robert A. Bruggeworth, invested $4,575.30 into 83 shares of MSA, for a cost per share of $55.00. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money.

Click here to find out which 9 other dividend bargains you can buy cheaper than insiders, at DividendChannel.com »

In trading on Thursday, bargain hunters could buy shares of MSA Safety Inc (NYSE: MSA) and achieve a cost basis 11.6% cheaper than Bruggeworth, with shares changing hands as low as $48.60 per share. It should be noted that Bruggeworth has collected $0.31/share in dividends since the time of their purchase, so they are currently down 11.1% on their purchase from a total return basis. MSA Safety Inc shares are currently trading up about 0.8% on the day. The chart below shows the one year performance of MSA shares, versus its 200 day moving average:

Looking at the chart above, MSA's low point in its 52 week range is $43.12 per share, with $61.08 as the 52 week high point — that compares with a last trade of $49.01. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months:

Purchased Insider Title Shares Price/Share Value
12/10/2014 Robert A. Bruggeworth Director 83 $55.00 $4,575.30

MSA makes up 2.84% of the ProShares S&P MidCap 400 Dividend Aristocrats ETF (AMEX: REGL)


Special Offer: Establish a secure stream of income during your retirement years by following the Retiree Income Portfolio with this free 30 day trial